The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 4-(2-(benzo[d][1,3]dioxol-5-yl)-4-oxo-1,2-dihydroquinazolin-3(4H)-yl)butanoate ID: ALA3585833
PubChem CID: 122179904
Max Phase: Preclinical
Molecular Formula: C20H20N2O5
Molecular Weight: 368.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)CCCN1C(=O)c2ccccc2NC1c1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C20H20N2O5/c1-25-18(23)7-4-10-22-19(13-8-9-16-17(11-13)27-12-26-16)21-15-6-3-2-5-14(15)20(22)24/h2-3,5-6,8-9,11,19,21H,4,7,10,12H2,1H3
Standard InChI Key: UAFKHKMLMDSULZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2928 2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9010 -2.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2102 -3.7707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5081 -3.0108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5121 1.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8109 0.7403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1121 1.4882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.8090 -0.4597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.1506 0.8868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2240 -0.7442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5149 -1.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.9281 -3.4731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.8088 -2.2556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.9391 -1.0665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 2 0
2 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
23 13 1 0
3 13 1 0
12 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
23 24 2 0
16 25 1 0
24 16 1 0
24 27 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.39Molecular Weight (Monoisotopic): 368.1372AlogP: 2.94#Rotatable Bonds: 5Polar Surface Area: 77.10Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.45CX Basic pKa: ┄CX LogP: 3.05CX LogD: 3.05Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -0.49
References 1. Khattab SN, Haiba NS, Asal AM, Bekhit AA, Amer A, Abdel-Rahman HM, El-Faham A.. (2015) Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors., 23 (13): [PMID:25922182 ] [10.1016/j.bmc.2015.04.021 ]